Last reviewed · How we verify
Complicated Skin and Skin Structure E. Coli Infection
Approved treatments
- Tygacil · Fresenius Kabi
Tygacil works by binding to the 30S ribosomal subunit of bacteria, preventing the aminoacyl-tRNA from binding and thereby inhibiting protein synthesis. - Avelox · Bayer AG
Fourth-generation fluoroquinolone with the broadest spectrum, covering gram-positive, gram-negative, anaerobic, and atypical organisms. - Tygacil · Pfizer
Tigecycline is a tetracycline class antibacterial agent. - Avelox · Novartis Pharmaceuticals
- Invanz · Merck & Co.
Invanz works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Noroxin
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Complicated Skin and Skin Structure E. Coli Infection patent landscape — cliff calendar, originator estates, attackable patents
- Complicated Skin and Skin Structure E. Coli Infection treatment landscape brief
- Complicated Skin and Skin Structure E. Coli Infection treatment updates RSS
Frequently asked questions about Complicated Skin and Skin Structure E. Coli Infection
What drugs treat Complicated Skin and Skin Structure E. Coli Infection?
Tracked treatments include Tygacil, Avelox, Invanz, Noroxin.
What is the treatment for Complicated Skin and Skin Structure E. Coli Infection?
Standard treatment for Complicated Skin and Skin Structure E. Coli Infection includes Tygacil, Avelox, Invanz, Noroxin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Complicated Skin and Skin Structure E. Coli Infection patent cliff · Complicated Skin and Skin Structure E. Coli Infection CI report
- Treatment: Tygacil · Fresenius Kabi
- Treatment: Avelox · Bayer AG
- Treatment: Tygacil · Pfizer
- Treatment: Avelox · Novartis Pharmaceuticals
- Treatment: Invanz · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing